Jessica Fye

Stock Analyst at JP Morgan

(4.43)
# 367
Out of 5,036 analysts
213
Total ratings
60.74%
Success rate
14.77%
Average return

Stocks Rated by Jessica Fye

Alnylam Pharmaceuticals
Oct 13, 2025
Maintains: Overweight
Price Target: $475$473
Current: $474.00
Upside: -0.21%
Legend Biotech
Oct 9, 2025
Maintains: Overweight
Price Target: $78$76
Current: $32.86
Upside: +131.28%
Incyte
Oct 9, 2025
Maintains: Neutral
Price Target: $73$89
Current: $87.30
Upside: +1.95%
BioMarin Pharmaceutical
Oct 9, 2025
Maintains: Overweight
Price Target: $116$119
Current: $53.81
Upside: +121.15%
Ascendis Pharma
Oct 9, 2025
Maintains: Overweight
Price Target: $260$264
Current: $200.59
Upside: +31.61%
Vertex Pharmaceuticals
Oct 8, 2025
Maintains: Overweight
Price Target: $517$530
Current: $426.27
Upside: +24.33%
BeOne Medicines AG
Oct 8, 2025
Maintains: Overweight
Price Target: $345$385
Current: $315.74
Upside: +21.94%
Ionis Pharmaceuticals
Oct 8, 2025
Upgrades: Overweight
Price Target: $49$80
Current: $71.64
Upside: +11.67%
Crinetics Pharmaceuticals
Sep 24, 2025
Maintains: Overweight
Price Target: $53$52
Current: $42.85
Upside: +21.35%
BioNTech SE
Sep 22, 2025
Maintains: Neutral
Price Target: $116$121
Current: $106.89
Upside: +13.20%
Maintains: Overweight
Price Target: $53$77
Current: $68.98
Upside: +11.63%
Maintains: Neutral
Price Target: $34$35
Current: $31.45
Upside: +11.29%
Maintains: Overweight
Price Target: $111$135
Current: $165.31
Upside: -18.34%
Maintains: Neutral
Price Target: $60$63
Current: $66.88
Upside: -5.80%
Maintains: Overweight
Price Target: $350$330
Current: $422.53
Upside: -21.90%
Maintains: Underweight
Price Target: $33$26
Current: $27.49
Upside: -5.42%
Maintains: Overweight
Price Target: $10$13
Current: $6.99
Upside: +86.11%
Maintains: Overweight
Price Target: $54$50
Current: $33.57
Upside: +48.94%
Maintains: Neutral
Price Target: $29$28
Current: $14.13
Upside: +98.16%
Maintains: Overweight
Price Target: $200$209
Current: $137.50
Upside: +52.00%
Maintains: Overweight
Price Target: $28$24
Current: $16.96
Upside: +41.51%
Initiates: Overweight
Price Target: $30
Current: $15.31
Upside: +95.95%
Maintains: Neutral
Price Target: $6$13
Current: $34.68
Upside: -62.51%
Reinstates: Underweight
Price Target: n/a
Current: $59.38
Upside: -
Reinstates: Underweight
Price Target: n/a
Current: $9.45
Upside: -
Reinstates: Neutral
Price Target: n/a
Current: $2.79
Upside: -
Reinstates: Underweight
Price Target: n/a
Current: $19.94
Upside: -
Downgrades: Underweight
Price Target: n/a
Current: $1.51
Upside: -
Initiates: Overweight
Price Target: $22
Current: $1.47
Upside: +1,396.60%
Upgrades: Neutral
Price Target: $7
Current: $1.44
Upside: +386.11%
Downgrades: Underweight
Price Target: n/a
Current: $10.05
Upside: -
Downgrades: Underweight
Price Target: n/a
Current: $8.59
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $11.01
Upside: -